Comparing Differing Financial Incentive Structures for Increasing Antidepressant Adherence Among Adults
ADAPT
Antidepressant Medication Adherence in Adults With Depression
1 other identifier
interventional
120
1 country
1
Brief Summary
The investigators will test using financial incentives by leveraging decision-making biases to improve adherence to antidepressants among adults newly prescribed antidepressants. This study will compare the effects of usual care, increasing financial incentives, and decreasing financial incentives on daily antidepressant medication adherence and depression symptom control of non-elderly adults with Major Depressive Disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Mar 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2018
CompletedFirst Posted
Study publicly available on registry
February 22, 2018
CompletedStudy Start
First participant enrolled
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 26, 2019
CompletedOctober 15, 2019
October 1, 2019
1.6 years
February 15, 2018
October 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Antidepressant adherence
The number of antidepressant daily doses taken during the initial six weeks of treatment
Daily for first 6 weeks of study
Secondary Outcomes (2)
Antidepressant adherence post-intervention
Daily between 6 and 12 weeks
Depression symptoms
At baseline, 6 week follow-up, and 12 week follow-up
Study Arms (3)
Escalating Incentives
EXPERIMENTALParticipants assigned to the escalating financial incentives will receive an increasing financial incentive for taking their antidepressant medication for the initial 6 weeks of treatment.
De-escalating Incentives
EXPERIMENTALParticipants assigned to the de-escalating financial incentives will receive a decreasing financial incentive for taking their antidepressant medication for the initial 6 weeks of treatment.
Control
NO INTERVENTIONParticipants in this condition will receive usual care.
Interventions
Providing money for taking antidepressant medication
Eligibility Criteria
You may qualify if:
- Prescribed antidepressant
- Plan to take antidepressant as prescribed
- Working cell phone that allows texting
- Score on PHQ-9 ≥ 10
You may not qualify if:
- No antidepressant use in last 90 days
- Never been diagnosed with bipolar disorder, schizophrenia, or schizoaffective disorder
- Not currently pregnant or breastfeeding
- No other serious medical condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- Columbia Universitycollaborator
Study Sites (1)
University of Pennsylvania Health System
Philadelphia, Pennsylvania, 19104, United States
Related Publications (2)
Marcus SC, Reilly ME, Zentgraf K, Volpp KG, Olfson M. Effect of Escalating and Deescalating Financial Incentives vs Usual Care to Improve Antidepressant Adherence: A Pilot Randomized Clinical Trial. JAMA Psychiatry. 2021 Feb 1;78(2):222-224. doi: 10.1001/jamapsychiatry.2020.3000.
PMID: 32965464DERIVEDBeidas RS, Volpp KG, Buttenheim AN, Marcus SC, Olfson M, Pellecchia M, Stewart RE, Williams NJ, Becker-Haimes EM, Candon M, Cidav Z, Fishman J, Lieberman A, Zentgraf K, Mandell D. Transforming Mental Health Delivery Through Behavioral Economics and Implementation Science: Protocol for Three Exploratory Projects. JMIR Res Protoc. 2019 Feb 12;8(2):e12121. doi: 10.2196/12121.
PMID: 30747719DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Marcus, PhD
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 15, 2018
First Posted
February 22, 2018
Study Start
March 1, 2018
Primary Completion
September 26, 2019
Study Completion
September 26, 2019
Last Updated
October 15, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share